睿创微纳(688002) - 2020 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders was ¥464,775,049.96, representing a significant increase of 359.43% year-on-year[5]. - Operating revenue for the first nine months was ¥1,077,579,530.46, up 167.89% from the same period last year[5]. - Basic earnings per share increased to ¥1.0444, reflecting a growth of 311.18% year-on-year[7]. - The return on weighted average net assets rose to 18.10%, an increase of 10.37 percentage points compared to the previous year[7]. - The company reported a net profit of RMB 758,485,907.67, a 141.42% increase from RMB 314,180,857.72 in the previous year[15]. - The net profit for the third quarter was 465.02 million RMB, an increase of 359.59% compared to the same period last year[16]. - The net profit for Q3 2020 was ¥156,546,454.95, compared to ¥36,480,898.08 in Q3 2019, marking an increase of about 328.5%[29]. - The total profit for Q3 2020 was ¥93,809,070.10, compared to ¥23,471,576.34 in Q3 2019, representing an increase of 299.5%[34]. Revenue and Sales - The company's operating revenue for the first nine months of 2020 reached RMB 1,077,579,530.46, a 167.89% increase compared to RMB 402,242,654.28 in the same period of 2019[15]. - The sales revenue from temperature measurement-related products reached 296.84 million RMB, a staggering increase of 12,100% year-on-year[16]. - Domestic and overseas main business revenues were 690.55 million RMB and 379.12 million RMB, with growth rates of 155.02% and 191.34% respectively[16]. - The sales revenue from civilian products reached 789.75 million RMB, accounting for 73.83% of total operating income, with a growth of 156.17% year-on-year[16]. - Total operating revenue for Q3 2020 reached ¥384,394,373.20, a significant increase from ¥148,198,492.11 in Q3 2019, representing a growth of approximately 159.5%[28]. - The company's operating revenue for Q3 2020 reached ¥140,785,282.04, a significant increase of 160.8% compared to ¥53,875,666.07 in Q3 2019[32]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥3,281,079,251.71, an increase of 28.96% compared to the end of the previous year[5]. - Total liabilities reached CNY 493,962,127.79, compared to CNY 201,695,747.53, indicating an increase of about 145%[23]. - Current assets totaled CNY 2,498,460,722.52, compared to CNY 2,070,425,102.05, reflecting an increase of about 21%[22]. - Non-current assets amounted to CNY 782,618,529.19, an increase from CNY 473,839,574.85, which is a growth of around 65%[22]. - The total assets of the company as of the end of Q3 2020 were ¥2,545,769,477.30, compared to ¥2,279,365,481.03 at the end of Q3 2019, indicating an increase of about 11.7%[27]. - Total liabilities amounted to ¥201,695,747.53, with non-current liabilities at ¥66,748,937.24 and current liabilities at ¥134,946,810.29[43]. Cash Flow - The net cash flow from operating activities for the first nine months was ¥25,615,994.70, a 72.22% increase compared to the previous year[5]. - Cash flow from operating activities increased by 72.22% to 256.16 million RMB compared to the same period last year[17]. - The company reported a significant decrease in cash flow from investing activities, improving from -1,464.00 million RMB to -305.17 million RMB, a change of 79.16%[17]. - The company’s cash flow from financing activities decreased by 97.59% to 27.31 million RMB, primarily due to the previous year's fundraising activities[18]. - The cash flow from operating activities for the first three quarters of 2020 was ¥927,180,176.67, compared to ¥340,250,505.47 in the same period of 2019, indicating a growth of 172.5%[36]. - The company reported a net cash flow from operating activities of ¥25,615,994.70 for Q3 2020, compared to ¥14,873,627.29 in Q3 2019, an increase of 72.5%[37]. Research and Development - Research and development expenses accounted for 11.59% of operating revenue, a decrease of 6.20 percentage points from the previous year[7]. - Research and development expenses increased by 74.50% to RMB 124,844,807.02 from RMB 71,545,232.66, reflecting the company's commitment to R&D[15]. - Research and development expenses in Q3 2020 amounted to ¥55,570,875.53, up from ¥24,128,728.21 in Q3 2019, reflecting a growth of approximately 130.5%[29]. - Research and development expenses increased to ¥15,391,223.25 in Q3 2020, up from ¥9,525,644.29 in Q3 2019, marking a rise of 61.5%[32]. Shareholder Information - The total number of shareholders at the end of the reporting period was 14,721, with the largest shareholder holding 15.37% of the shares[11]. - The company is actively pursuing stock incentive plans to enhance employee motivation and align interests with shareholders[19]. - Shareholders' equity rose to CNY 2,787,117,123.92 from CNY 2,342,568,929.37, reflecting an increase of approximately 19%[24]. - Total equity attributable to shareholders reached ¥2,341,978,767.07, with retained earnings of ¥314,180,857.72 and surplus reserves of ¥22,059,980.65[44].